The RCVS is encouraging veterinary surgeons, veterinary nurses and other members of the practice team to respond to a government consultation on changing the law to introduce English language testing for veterinary surgeons who have qualified from elsewhere in the European Union.
Under the proposals outlined in the consultation by the Department for Environment, Food and Rural Affairs (Defra), the test would apply before an individual joined the Register and only where the RCVS had ‘serious and concrete doubts’ about their English language abilities. The plan to consult on this issue had been welcomed by RCVS Council at its June 2015 meeting.
Every year, around half of all new veterinary surgeon registrants are from outside the UK, the majority from other EU or European Economic Area (EEA) countries. These individuals fall within the scope of the Mutual Recognition of Professional Qualifications (MRPQ) Directive, which applies to all EU nationals wishing to practise in a regulated profession in another member state.
Last year, a revised version of the MRPQ Directive came into force, which made a number of changes, including clarifying and reinforcing the role of competent authorities such as the RCVS. One of these changes is that language testing is expressly permitted, but only where serious concerns have been identified.
Gordon Hockey, RCVS Registrar, said: “Under the current legislation the College is not able to bar someone from joining the Register, and therefore practising, on the basis of language ability, even where we may have serious concerns.
“I would encourage all veterinary surgeons, veterinary nurses and other members of the practice team to engage with this consultation and consider whether the College should have the right to impose a language test where it has serious doubts, more in line with medical doctors, and the form such testing would take.”
Under the proposals, applicants would be asked a series of questions concerning their language qualifications, experience and general ability to use the English language before registering. Depending on how they answer the questions they may then have to pass a language test before registering, or delay their application while they improve their language skills.
The consultation results will inform the College’s work with Defra to determine whether to proceed with implementation and, if so, to develop the most appropriate system of language testing. The College would implement language testing for veterinary nurses in parallel with any changes for veterinary surgeons.
Those who wish to take part in the consultation can do so at https://consult.defra.gov.uk/animal-health-and-welfare/vet_language_controls. The deadline for responses is Wednesday 30 September 2015.
Rodney (pictured right) has spent the last 26 years practising in the USA, latterly at the California-based Advanced Veterinary Specialists & Animal Specialty Group.
After growing up in Zimbabwe and graduating from the University of Pretoria in South Africa in 1985, he moved to London, where he became an MRCVS, and thence to the USA.
He undertook a small animal internship at the Animal Medical Centre in Manhattan, before moving to the Ohio State University for his residency in medical oncology in 1989. He achieved Board Certification in medical oncology in 1994 and in radiation oncology in 2000.
Rodney specialises in the application of multi-modality therapy protocols for the treatment of cancer in animals, and has conducted research on the phenomenon of multi-drug resistance, mast cell tumour and oral melanoma.
He said: "Thirty-something years on, I have come back to the UK as a specialist, where I started as a GP. Living in the UK also brings me much closer to my family, which is very important to me.
"Over the years, veterinary practice in the USA has changed significantly, where it has become more corporate and less personal. I enjoy being part of a new group where typically it is much closer, friendlier and more like a family."
Rodney now plans to oversee the development of a comprehensive oncology department to include chemotherapy, surgery, radiation therapy, immune-therapy and molecular targeted therapy.
He said his work at Paragon will focus on educating referring vets and clients about what is possible in the oncology field.
He said: "My job will be about increasing the level of knowledge, both of owners and general practitioners, of how we treat cancer in animals.
"It can be a scary disease and the first door an owner needs to step through, is understanding that treating a pet is very different to treating a human.
"The intention in humans is usually to cure but with pets, it is more about providing a good quality of life for as long as possible.
"There can be a fear of cancer therapy but if you stick to the protocols, it is no different to treating any other chronic incurable diseases. We use the safest methods with an abundance of caution and try to make sure that the treatment is not worse than the disease.
"It’s about internal training too, from reception right up to nurses and interns, looking at what we do and how we do it, to optimize the quality of life of the pet and their owners.
"I would like to see an oncology department that considers the emotional, financial, time and patient concerns of the owners, so they feel their commitment to cancer treatment for their pet is not a commitment to putting their pet or themselves through a difficult time."
Veterinary Review and Practice Heart magazines have ceased publication.
The former was first launched 15 years ago by John Alborough, and sold to Onstream Communications in May 2007.
Mark Johnston, Managing Director of Onstream Communications said: "It wasn't commercially viable running a full publishing team for two magazines, especially in the current economic environment, so we're consolidating our activities and concentrating on electronic media".
These include the peer-reviewed online clinical information services: Canis, Felis, Equis and Lapis and the provision of websites for veterinary practices and companies wishing to promote themselves and their products and services.
Only about a third of vets and a quarter of nurses believe in a God, according to a poll carried out amongst the members of www.vetsurgeon.org and www.vetnurse.co.uk
The poll offered four possible responses to the question: Does God exist? The results from 124 vets were:
Interestingly, the results were more polarised amongst vets than nurses. Fewer nurses described themselves as believers (24.4%) or atheists (39.5%), with many more describing themselves as agnostic (33.6%).
The VetSurgeon poll suggests that vets and nurses are less likely to believe in God than the general population. In 2004, a survey commissioned by the BBC found that 56% of Britons believed in God, and in 2005 a survey by the European Commission found that 38% of Britons believed in God.
When it comes to religion, it seems that vets have more in common with today's teenagers. A survey announced by Penguin books yesterday to mark the publication of 'Killing God' found that only 34% of those aged 13 to 18 believe in God.
Another survey in 2008 found that only 3.3% of Royal Society fellows believed in God, causing researchers to conclude that people with a higher IQ are less likely to have faith, a finding which tallies with a previous Gallup survey which showed that American postgraduate degree holders were less likely to believe in God than those who had been through high school only.
So, hard to tell whether the lack of belief in God amongst vets is due to superior intellect, or developmental problems!
Either way, good to see that the God complex is alive and well in the veterinary profession: 4.8% voted for the fourth option in the VetSurgeon poll, which was: "Don't be so silly, I AM God"
Michael qualified from the University of Glasgow in 2009 and then worked in first opinion practice in Buckinghamshire and Northern Ireland. He then returned to the University of Glasgow in 2012 to further his training and experience in oncology by completing four years of additional training. He completed an ECVIM residency in oncology in 2016 and became a Diplomate of the European College of Veterinary Internal Medicine and a European Specialist in Oncology in 2017. Michael worked at a private referral practice in Surrey prior to joining Fitzpatrick Referrals. Earlier this year, Michael was awarded a Masters degree in Veterinary Medicine. This additional qualification researched canine mast cell tumours.
Michael said: "I am absolutely delighted to have joined Fitzpatrick Referrals Oncology and Soft Tissue hospital. I have had a long-standing ambition to work as part of the fantastic team here since visiting the hospital during my specialist training in 2015. At this visit, I immediately felt at home in a group of people driven to deliver the very best compassionate care for dogs and cats.
"My ambition is to develop the very best ways to minimise the impact that cancer has on animals. I know that Fitzpatrick Referrals is the best environment for me to be able to achieve this. Throughout the hospital, there is an amazing positive attitude and a collective drive to improve the overall care we can give to pets with cancer. I am also excited by the opportunity to be able to help others to achieve their goals in improving cancer care for pets."
According to Davies, Sharpsmart is the world’s safest and most environmentally responsible sharps and clinical waste management system, proven to:
Ellie West, anaesthetist at Davies and Green Group leader said: "We are really excited to have the opportunity to be the first veterinary centre to be working with Sharpsmart and are already seeing great results in carbon reduction and we look forward to sharing our results later in 2019."
Adrian Giles, Total Waste Program Manager for Sharpsmart added: "Working with Davies has enabled us to showcase our safety engineered sharps system in a new and exciting arena where sharps safety and sustainability are a priority.
"The transition to Sharpsmart was seamless and was completed across the centre in a day without any challenges. Face-to-face training was provided to staff along with touch point education material. We look forward to strengthening our partnership with Davies over the coming months and years."
As part of its green drive, Davies will be hosting 'Sustainability CPD' for referring vets on May 2nd 2019 at its HQ in Higham Gobion, Hertforshire.
Ellie West said: "Run by the Sustainability Leads at DVS, this evening aims to increase your carbon literacy, explore the challenges and barriers to improving sustainability in your daily practice and find some positive solutions to implement sustainability. The challenges which we have faced at DVS will be explored, along with the co-benefits of sustainability to our business, and useful resources to help your practice to be more environmentally friendly and resilient will be highlighted."
You can book your place here https://vetspecialists.co.uk/events/davies-first-sustainability-cpd-for-referring-vets/ or contact Ellie.West@vetspecialists.co.uk if you are interested in attending or would like more information.
Davies has also produced a suite of Waste Segregation Posters which are proving popular with their referring practices. You can find out more and view the posters here https://vetspecialists.co.uk/sustainability/sustainability-initiatives-at-davies-your-questions-answered/.
For more information or to receive print ready PDFs, contact marketing@vetspecialists.co.uk
Andrew Parry MRCVS, an RCVS and European Specialist, heads Diagnostic Imaging at Willows. He said: "Our previous CT scanner was excellent but all technology moves on. We wanted to ensure we maintained our position at the forefront of specialist veterinary diagnostic imaging.
"We have a large cardiology service and the Siemens scanner, with its advanced cardiac imaging package, will allow the team to gain a huge amount of information about cardiac disease and other vascular abnormalities. This combination of technology and on-site Specialist imaging expertise is unusual, even at a referral level.
"A further advantage of the new scanner is its use of tin filters, which enables it to produce high quality images of regions of high contrast, such as feline chests."
Willows has also invested in a software package which does all sorts of clever stuff to bring the images to life for clients.
He said: “The syngo.via software allows anyone to access and manipulate images from any computer in the hospital. This can be building complex models or more straightforward multiplanar reconstruction.
"Specialists can show models to clients immediately, while surgeons can manipulate images in theatre and all clinicians can view and interact with images from their own working environment.
"Additionally, we have invested in Siemens-manufactured software called syngo.via Cinematic VRT, which means we can build, rotate and fly through volume rendered CT models with clients, giving them a dynamic understanding of anatomy and pathology."
The product was one of eight NSAIDS that had been suspended following a European ruling that an excipient, diethanolamine, may pose a risk to human health.
Allevinix is licensed for both intravenous (I/V) and intramuscular (I/M) administration over one to three days in cattle. It has a dose rate of 4ml per 100kg liveweight in cattle, and milk withdrawal times of 24 hours after I/V injection and 36 hours after I/M injection.
Ceva says Allevinix reaches peak plasma levels (CMax) approximately 30 minutes following I/M injection. It is available in 100ml and 250ml vials.
Peter Keyte, ruminant business unit manager at Ceva Animal Health, said: "Allevinix is the only flunixin licensed for both intramuscular and intravenous administration in cattle and provides both vets and farmers with a cost-effective, fast-acting and versatile NSAID that is a useful addition to the range of NSAID options available."
For more information, contact your Ceva account manager, email cevauk@ceva.com or call the ruminant marketing department at Ceva on 01494 781510.
Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.
Metacam, which contains the non-steroidal anti-inflammatory drug (NSAID) meloxicam, is indicated for the treatment of non-infectious locomotor disorders to reduce inflammation and signs of lameness. It is also licensed for the treatment of mastitis-metritis-agalactia (MMA) syndrome in sows, when used alongside appropriate antibiotic therapy. MMA is a multifactorial condition that can threaten the health of the sow and the lives of her piglets due to a marked decrease or complete cessation in milk production.
Boehringer says treatment with Metacam15 mg/ml oral suspension helps control inflammation and pain associated with the condition, thereby helping to restore productivity and wellbeing in the sow and her offspring.
Metacam 15mg/ml oral suspension for pigs supplements the existing injectable formulation and has been introduced to its increase flexibility and ease of use, and to reduce the potential stress than can be caused when injecting newly-farrowed sows. The palatable suspension can be given mixed with a small quantity of feed or can be administered directly into the mouth.
The Wellington-based hospital is hoping to announce its first resident at the start of next year, who will work under the guidance of Fran Taylor-Brown and Tom Cardy.
This is the first residency programme to be conducted at Cave and has been launched by Fran who, along with Tom, is an EBVS and RCVS specialist in veterinary neurology.
Fran said: "The ECVN accreditation is an important milestone for us as we look to develop and expand our expertise in neurology.
"We are currently undertaking a major recruitment drive and having the capability to offer specialist training in this discipline is another feather in the cap.
"We’re hopeful this approval will open the door to allow clinicians in other disciplines to receive specialist-level training with us in the future."
Cave has also introduced an internship programme to support the growth of the team and has taken on Samantha Gilbert a graduate of James Cook University in Australia.
The clinic is led by Sebastien Behr MRCVS, an RCVS Specialist in Neurology. Patients will benefit from access to the referral centre's MRI scanner and its specialist imaging, anaesthesia and neurology teams.
Dr Behr said: "We are very excited to have launched this specialist clinic. Following detailed consultations with pet owners, the animals will be treated to the very highest level and bespoke care designed for each patient."
The practice is offering a fixed price package for routine diagnostic procedures.
For more information, visit www.willows.uk.net or contact the neurology team on 0121 721 7070.
The programme commences in October 2017 and includes ten days of hands-on practical training based at the CPD Solutions Training Centre in Studley near Birmingham, where surgery tutors will help veterinary surgeons refine their techniques in small group sessions.
CPD Solutions says the main differences with existing PgCert programmes include a stronger emphasis on practical training, a lack of lecture days and the grouping together of practical days in three attendance sessions.
The company says that many current PgCerts run for 2 to five years, so its programme provides an opportunity for those who'd prefer to complete their training and gain a PgCert qualification in a much shorter timeframe.
Susie Coughlan, MD at CPD Solutions said: "Our experience is that vets get the most out of hands-on practical training in a structured and supportive environment, combined with reflective application of their new skills in practice. We set out to replicate this with the new PgCert – all attendance sessions are practical, and the course provides support for developing reflective work-based learning that vets can then use throughout their careers."
David Perrin, Head of Professional Development at the Centre for Work-Related Studies at Chester University said: "The University is proud to be working with CPD Solutions as leading educationalists in the field of veterinary professional development. We have put together a high-quality product that brings together our work-based learning expertise with CPD Solutions specialist knowledge, and this will be of wide interest to practitioners in the field."
For more information, contact CPD Solutions on 0151 328 0444 or visit www.pgcertsurg.com
Novartis Animal Health has issued the following statement concerning the supply of acepromazine (ACP) injectable in the UK:
"Recent upgrades to Novartis Animal Health’s manufacturing plant in the UK have resulted in the site becoming a worldwide centre of excellence for the production of bulk liquids. This upgrade has had an impact on the manufacture of ACP 2mg/ml and 10mg/ml injectable products, which will no longer be produced in the UK.
From January 2011, Novartis Animal Health will no longer be able to supply ACP Injection 2mg/ml or ACP Injection 10mg/ml to wholesalers. However, it is not Novartis’ intention to discontinue the supply of acepromazine injectable; in order to ensure consistency of supply to the UK market the company will be importing the Vetoquinol French product Calmivet.
Calmivet is a monovalent acepromazine injection licensed for use in dogs, cats and horses, available as a 5mg/ml injection, 50ml vial.
In order to obtain Calmivet from wholesalers, veterinarians will need to apply for a free of charge Special Import Certificate from the VMD. This can be completed on line at www.vmd.gov.uk.
It is anticipated that this situation will continue for at least the first 6 months of 2011, until an alternative manufacturing site is established. As soon as we have more information on the timelines this will be communicated.
A full communication including a prep room reminder poster and Calmivet product leaflet has been mailed to all UK practices.
Vetoquinol UK are not responsible for the distribution or technical support of this product, so any queries should be directed to Novartis Animal Health UK on 01276 694402.
The production and supply of ACP Tablets 10mg remains unaffected."
The congress, which is now in its 6th year, also saw Millie Barnsley from Dudley scoop Nurse of the Year and Cassandra Pearson from Walsall win Client Care Co-ordinator of the Year.
Four more team members were also were singled out for their achievements, including Senior Vet Dr Laura Pugh, from Derby, who won the Quality Award, Veterinary Nurse Ann-Marie Mayren, who was presented with the Directors Choice Award, Dr Tom Cammack MRCVS, who was named Best New Team Member and Ed Newbold, who won the Leadership Award.
White Cross Vets' Managing Director Tim Harrison said: "It’s been a very special congress this year, as we are also celebrating 80 years since White Cross Vets was founded. It was really hard choosing the award winners, as there have been some fantastic examples of people going above and beyond, but Emily, Katherine, Millie, Cassandra, Laura, Ann-Marie, Tom and Ed were all very deserving winners, who are incredibly passionate about what they do.
Tim added: "In addition to recognising our award winners, we saw the culmination of our 80 prizes in 80 days competition on the final night of our congress, with veterinary nurse Amy Hood from Middlesbrough winning the star prize of an all-expenses paid trip to New York.
"As is now tradition at congress, we also randomly selected a Client Care Co-ordinator, vet nurse and vet to go to the Veterinary Meeting & Expo (formerly known as NAVC) in Orlando, Florida. Katrina Robinson, Isobel Hobbins and Dr Alex Beech will be heading to America for some sunshine and CPD in February next year."
"2017 has been a very successful year, we have opened two new practices, won several awards and were listed in The Sunday Times Top 100 companies to work for league table for the fifth year running. We also welcomed our 200th team member into the practice. The congress gave our whole family the chance to come together and celebrate all of our achievements and it was a huge success.
"The ethos of the White Cross Vets congress is to learn, make friends, have fun and reward success – and we certainly did that."
Hysolv says the vaccine, which was developed by IDT Biologika, has been used successfully in Germany, where 1.7 million doses have been prescribed. The company says field trials have shown that vaccination not only protected against clinical signs of influenza but also resulted in improvements in reproduction and piglet performance.
Two 1 ml doses of the inactivated vaccine can be injected intramuscularly three weeks apart to pigs from 56 days old, providing immunisation to the majority of animals within seven days.
Hysolv director, Geoff Hooper said: "Swine flu can be devastating to a herd and this vaccine will broaden protection, particularly when used with our existing vaccine Respiporc FLU3, which we are strongly advising."
Respiporc FLU3 protects against three other strains of swine flu (H1N1, H1N2 and H3N2). Hysolv says that when used together, the two vaccines protect pigs against the most relevant strains in the British Isles.
Geoff added: "There have been several flu pandemics throughout the years – the latest in 2009. It is not possible to predict the emergence of a pandemic strain accurately but this vaccine combined with Respiporc FLU3 will greatly decrease the chance of pigs becoming infected."
Bovilis Rotavec Corona is used for the active immunisation of pregnant cows and heifers, 12-3 weeks pre-calving, to raise antibodies against rotavirus, coronavirus and E. coli F5 (K99). Calves gain protection by drinking the fortified colostrum from their vaccinated mothers.
The company says the new license indication will mean greater usage flexibility for UK cattle producers focusing on immunity-led prevention of infectious calf scours.
MSD ruminant veterinary adviser Dr Kat Baxter-Smith said: "On the old license, this vaccine needed to be used within eight hours of opening, so this will be a significant benefit-led change for suckler beef and dairy producers.
"For all-year-round calving dairy herds, for example – that may want to vaccinate successive pregnant dams on different days – it will make an opened bottle of vaccine last much longer. Those running batch calving herds with a long calving period should also benefit. We hope this will help reduce unnecessary wastage of the vaccine on farm and save farmers money.”
MSD says it will still be crucial to store the vaccine properly – upright and refrigerated (at 2-8°C) before and after broaching, and after first use. A broached vial will be able to be used once more during the next 28 days after the first vaccination event and then discarded. Vaccination equipment such as needles and syringes should be sterilized. Use of a multi-dose syringe to minimise vaccine contamination and excessive broaching is recommended.
The vaccine vials should still be shaken well before use. The injection should be made through an area of clean, dry skin with precautions taken against contamination.
According to the BVA, the problem is usually related to the cost of treatment, with 90% of vets saying that they or a member of their team have been challenged over their fees or charges and 98% saying that at some time they feel under pressure to waive fees or accept the promise of late payment.
Predictably, the problem is more commonly reported by those working in companion animal or mixed practice, with 89% reporting some form of intimidating experience. Younger vets and female vets were also significantly more likely to have experienced some form of intimidation.
The survey has prompted the BVA and the British Veterinary Nursing Association to issue advice concerning how to deal with intimidating clients.
BVNA President Sam Morgan said: "These statistics make for sad reading, but are certainly not surprising. Working within practice we have all either been subject to or witnessed that 'difficult' client, but we must remember any form of harassment is unacceptable. It’s important not to feel alone in these situations and to ensure there is awareness and support throughout the veterinary team."
BVA President John Fishwick, said: "Every situation is different and has to be dealt with on an individual basis, but it’s concerning to see the figures around challenging client behaviour and fees. Owning an animal is an important responsibility and will cost tens of thousands of pounds over its lifetime.
"It’s important for everyone in the vet team to take pride in the healthcare and treatment they deliver, and, equally, they must feel valued for their services. These figures emphasise the importance of managing expectations around fees by ensuring a two-way discussion about options and costs so clients can make a decision in collaboration with the veterinary team."
The BVA/BVNA advice for dealing with intimidating clients is as follows:
Photo: Dimitry A / Shutterstock
Chris Jordan, veterinary surgeon at Companion Care vets in Chingford, Essex, is the 500th vet to sign up to the RCVS Certificate in Advanced Veterinary Practice (CertAVP), which was launched in 2007.
Having completed his Professional Development Phase in July, Chris is now working towards a designated certificate in Small Animal Surgery. He said: "The qualification looks well structured and I think it will serve me well whether I continue as a general practitioner or take up a more surgery-focused role."
Freda Andrews, RCVS Head of Education, said: "The modular approach means vets have much more choice about how and what they study. All certificates show the modules assessed, so that it is easy for veterinary employers to see what a vet has studied, whether or not they have taken a 'named' certificate."
To gain the qualification, vets must first enrol with the RCVS, and then enter for assessment in a combination of core and optional modules through an RCVS-accredited institution. Vets then have ten years in which to complete the qualification. Study can be entirely self-directed; however, there are a number of courses on offer from educational institutions to help vets prepare for assessment. Distance and online learning is a feature of many of these courses.
Vets who want to pursue an area of interest for continuing professional development without working towards any certificate, can equally enrol for assessment in any of the 85 individual modules currently available; this is done directly through the institutions offering assessment and does not need enrolment with the RCVS. Full details of enrolment and module requirements can be found at www.rcvs.org.uk/modcerts
Ceva Animal Health has published video recordings of its second 'Human and Veterinary Crosstalk Symposium on Aldosterone'.
Over 100 world experts in human and veterinary cardiology from 15 different countries attended the symposium, where delegates explored the similarities and differences between human and canine heart failure, and shared the latest research on the harmful effects of aldosterone.
The recordings from this meeting are now available to watch on http://cardiosymposium2011.ceva.com/, where you can also download the full proceedings.
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
The company says the system uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence to deliver accurate testing results at the time of visit, within 9 minutes in fact, giving veterinary surgeons the ability to diagnose and treat patients quickly, without the need for a second appointment.
Vetscan Imagyst will detect the eggs, cysts, and oocysts of whipworm, hookworm, roundworm, Giardia, and coccidia
Richard Goldstein, DVM, DACVIM, DECVIM-CA, VP Global Diagnostics Medical Affairs at Zoetis, said: "Parasites are a threat throughout the year, making routine monitoring critical to pet health.
“With Vetscan Imagyst, the ability to have accurate, fast results at the point-of-care empowers veterinarians to diagnose and treat in the same visit, increasing compliance and eliminating follow-up appointments and call backs, thus enhancing the overall pet owner experience.”
Vetscan Imagyst will launch in the UK next week. For more information, contact your Zoetis representative or visit at www.vetscanimagyst.com.
The webinars already available cover subjects like cardiopulmonary resuscitation (CPR), emergency diagnostics and traumatic brain injury, presented by experienced emergency vets Aoife Reid, Liron Levy-Hirsch and Jacqueline Seymour.
More content is due to be added to the library in the coming weeks, including guest webinars from TVM UK on rodenticide and seizure management, and from clinical psychologists Dr Jo Becket and Dr Jess Brown on “thrive, not just survive” and “when stress gets too much”. There will also be a session from ECC specialist Tobias Grave (pictured right) on how to deal with some of the most common pet emergencies.
Tobias will also be on hand to help veterinary surgeons and nurses whose practices use Vets Now for their out-of-hours service with both general advice and a second opinion on potentially complex cases via the new support line.
Tobias said: “Covid-19 is bringing fresh challenges to vets and vet nurses every day. With clinicians seeing a caseload which is mainly emergency and often having to triage patients over the phone or by video consult, it’s never been so important to come together as a profession.
"Both our webinars and our specialist support line for practices who use our service will help equip vet professionals with the skills and knowledge needed to deal with challenging emergencies in practice."
You can find Vets Now’s library of free ECC webinars here.
The RCVS has extended its alternative dispute resolution (ADR) trial until October 2015 and broadened its remit, allowing more cases to be considered.
The idea of the ADR is to provide an alternative form of resolution for the many concerns raised with the RCVS which do not meet the College's threshold for serious professional misconduct and are, therefore, not taken through its disciplinary process.
The trial, which was originally due to end in May 2015, aims to gather evidence needed to develop a permanent scheme.
As well as the time-frame being extended, the trial will now also be widened to include concerns raised about the treatment of horses and other equines - in addition to those raised about small animals.
The RCVS has also lowered the maximum financial award that can be recommended by the Ombudsman Services, a not-for-profit complaints resolution service which is administering the trial, to £3,000 for small animal cases. The maximum financial award that can be recommended by the Ombudsman Services in relation to equine cases remains at £10,000.
Nick Stace, RCVS Chief Executive, said: "The trial got off to a slower start than we expected and so we have decided to extend its length and breadth to allow more time and scope to gather the evidence and testimonies which we need to assess the trial.
"It's important to stress again that the trial is free, voluntary, as both parties must agree to take part, and that the recommendations made by the Ombudsman Services are not binding - it is up to either party as to whether they accept them."
The results of the trial will now be reported to the November 2015 meeting of RCVS Council. For further information about the ADR trial please visit www.rcvs.org.uk/adr
Sarah, who practices at Southfields Veterinary Specialists, was already a European and Royal College Specialist in oncology. Now, after studying for a year and passing the European College of Veterinary Internal Medicine (ECVIM) exams this autumn, she has now been recognised as a European Specialist in radiation oncology as well.
Sarah said: "I intend to use my experience to grow the radiation and oncology service at Southfields and, with the benefit of our new linear accelerator and state-of-the-art hospital, deliver the most advanced treatment options for our veterinary patients.
"I also intend to use my experience and expertise to contribute to the further development of radiation oncology as a specialist qualification in Europe."
Congratulations Sarah!
There's a complimentary counter top unit and pillow packs to help veterinary surgeons and nurses communicate the benefits of probiotics to clients. The unit can hold a cat and dog 30 sachet box of Purina Pro Plan FortiFlora from practice stock and the pillow packs can be used to dispense single sachets, so the client can trial the product with their pet at home.
At the same time, the company is encouraging vets and nurses to look at the evidence behind the probiotics they recommend. Although carried out a while ago now (2003 and 2011), two studies have shown that other diets claiming to contain probiotics generally did not meet the label claim when evaluated1,2.
Libby Sheridan, MVB MRCVS, Purina Veterinary Technical Affairs Manager, UK & Ireland says the efficacy of probiotics is thought to be strain-specific3 and recommends that clinicians critically assess the evidence for the particular strain and preparation of probiotics stocked or used.
Libby said: "The quality and efficacy of probiotics can vary and while in some cases there is strong evidence for efficacy in the targeted species, for others, the evidence is scant. Having experienced it myself, I know it's not always easy when working in a busy practice to take the time to ensure the evidence is there, but the studies back up that we should assess these things carefully before making a robust recommendation to our clients."
Most of the probiotics commercially available to veterinary professionals use the lactic acid bacterium Enterococcus faecium.
The particular strain and preparation of any probiotic will affect its ability to reach the large intestine, the expected site of action, intact. The evidence for the SF68 strain of Enterococcus faecium has been validated in a number of studies4-11 over recent years. Proven benefits of the SF68 strain include those focused on the gastrointestinal system where it supports canine and feline intestinal health and microflora balance and those with wider implications, such as support for a healthy immune system.
To obtain a unit or discuss the science, contact your Purina Veterinary Nutrition Partner or telephone the Purina Veterinary Nutrition Team on 0800 212161 quoting code VETPRESS.
References